Literature DB >> 15537594

The decline in receipt of substance abuse treatment by the privately insured, 1992-2001.

Tami L Mark1, Rosanna M Coffey.   

Abstract

This study examines underlying trends in substance abuse services financed by private insurance. Analyses are based on the 1992 and 2001 Medstat MarketScan database, a claims database from large employers. The percentage of beneficiaries using any substance abuse services declined by 23 percent from 1992 to 2001 (from 0.64 percent of enrollees to 0.49 percent of enrollees). This decline was evident in all categories: inpatient, outpatient, and pharmaceutical usage. Substance abuse spending per covered life (in constant dollars) dropped from about $21.16 in 1992 to about $5.58 in 2001 [corrected]

Entities:  

Mesh:

Year:  2004        PMID: 15537594     DOI: 10.1377/hlthaff.23.6.157

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  4 in total

1.  Equity in private insurance coverage for substance abuse: a perspective on parity.

Authors:  Colleen L Barry; Jody L Sindelar
Journal:  Health Aff (Millwood)       Date:  2007-10-23       Impact factor: 6.301

2.  Trends in alcohol services utilization from 1991-1992 to 2001-2002: ethnic group differences in the U.S. population.

Authors:  Karen G Chartier; Raul Caetano
Journal:  Alcohol Clin Exp Res       Date:  2011-05-16       Impact factor: 3.455

3.  Assessing Adolescent Substance Abuse Programs with Updated Quality Indicators: The Development of a Consumer Guide for Adolescent Treatment.

Authors:  John S Cacciola; Kathleen Meyers; Suzanne E Bates; Beth Rosenwasser; Amelia Arria; A Thomas McLellan
Journal:  J Child Adolesc Subst Abuse       Date:  2015-03-06

4.  Does higher cost mean better quality? evidence from highly-regarded adolescent drug treatment programs.

Authors:  Bruce R Schackman; Erick G Rojas; Jeremy Gans; Mathea Falco; Robert B Millman
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.